Early Feasibility Studies in the Neurovascular Space— MDIC and Jacobs Institute

EFS are essential in medical device development, allowing researchers to test new technologies in real-world settings, address potential challenges, and refine designs before larger trials. This session dives into neurovascular research, with speakers sharing specific examples of obstacles and breakthroughs, particularly in regulatory navigation and device adaptation. The discussion highlights the value of cross-sector collaboration by involving industry partners such as Philips, Siemens, and J&J. These efforts reflect a shared commitment to improving patient outcomes and streamlining pathways for innovative healthcare technologies.